← Open Payments lookup

ERIN PEARSON: Open Payments

NPI 1629658232 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,623 in 56 payments from 28 companies in 2025. Trend: 2023 $313 · 2024 $2,224 · 2025 $1,623

Food & beverage: $1,623
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation7$195
Celgene Corporation5$127
Astellas Pharma US Inc1$126
Syndax Pharmaceuticals, Inc.1$122
AstraZeneca Pharmaceuticals LP3$88
Genmab U.S., Inc.3$83
GENZYME CORPORATION3$68
Secura Bio, Inc.3$66
Daiichi Sankyo Inc.3$65
Legend Biotech USA Inc.1$63

Products named: SCEMBLIX, Vyloy, REVUFORJ, Epkinly, REBLOZYL, CALQUENCE, COPIKTRA, Vanflyta.

Industry payments across MA — which companies pay providers there.